Jefferies Reiterates a Hold Rating on CVS Health

By Austin Angelo

In a report released today, David Steinberg from Jefferies reiterated a Hold rating on CVS Health (NYSE: CVS), with a price target of $82. The company’s shares opened today at $79.71.

According to TipRanks.com, Steinberg is a 4-star analyst with an average return of 5.0% and a 47.3% success rate. Steinberg covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Spectrum Pharmaceuticals, and Supernus Pharmaceuticals.

CVS Health has an analyst consensus of Strong Buy, with a price target consensus of $89.

CVS Health’s market cap is currently $80.55B and has a P/E ratio of 16.34. The company has a book value ratio of 2.3805.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.